• Publication Practice Counsel is your trusted partner

    Slide title

    Write your caption here
    Button
  • customized solutions to meet your needs

    Slide title

    Write your caption here
    Button
  • Your Trusted Partner

    Slide title

    Write your caption here
    Button

Why Publication Practice Counsel?

Publication Practice Counsel is your trusted partner with experienced professionals to help you ensure ethical publication practices and compliance within your organization. With over 20 years of experience in scientific communications and publication ethics & compliance, we are the publication specialist that pharmaceutical, biotech, and medical device companies; clinical and academic research organizations; and academic researchers can rely on.

Your TRUSTED partner for PUBLICATION EXCELLENCE

Testimonials

“…by far the best Publication professional I have ever worked with. Relationship with KOLs and investigators is phenomenal and has the ability to get articles written and published in very high quality journals. Astutely commercially oriented and assist in the development of marketing and sales messages and programs.”


M. Lambertson, BioPharmaceutical Executive

Publications Practice Counsel

“…incredibly knowledgeable on all matters related to Pharma supported clinical trial publications. Can provide guidance and clear actionable steps on issues such as authorship, disclosures, Sunshine and EFPIA reporting of TOV, metrics, audit readiness. Instrumental in developing and implementing corporate SOPs, guidance's and Publications policy. Knowledge and advice are a great asset to anyone looking to improve or update their publications approach.”

S. Owen, Head of Global Scientific Communications, Novartis Oncology 

Publications Practice Counsel

“…collaborative and knowledgeable professional. Very good technical understanding of our products/clinical data and worked with the clinical team to ensure high quality publications. Always provided sound guidance on how to manage sensitive authorship issues with our external collaborators and has a good understanding of all of the regulations and guidelines pertaining to publications and scientific disclosures.”


K. McKerracher, VP, Global Program Head, Novartis Oncology

Publications Practice Counsel
tb-med

tb-med

FerGene

FerGene

Argenx_logo

Argenx_logo

mmunomet

mmunomet

tersera

tersera

TG+Therapeutics

TG+Therapeutics

Beyondspring

Beyondspring

jazz+pharmaceuticals

jazz+pharmaceuticals

Daiichi

Daiichi

celgene

celgene

exicon

exicon

metavent_logo

metavent_logo

novartis-logo

novartis-logo

amicus therapeutics

amicus therapeutics

Contact Us